Asian Spectator

The Times Real Estate

.

Phase 1 Drug Candidate GLR2007 Developed by Gan Lee has been...

  • Written by LATEST ASIANET NEWS RELEASES
  • Published in Asia Net
BEIJING and BRIDGEWATER, N.J., Jan. 30, 2021 /PRNewswire-AsiaNet/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for GLR2007, ...

Authors: LATEST ASIANET NEWS RELEASES

Read more

Magazine

Expert Legal Help | Personal Injury Lawyer in Brisbane

Suffering a personal injury can be a traumatic and life-changing experience, leaving you wondering what to do next. Navigating the complex world of personal injury law in Brisbane can be overwhelmin...

#IndonesiaGelap: Alarm bagi publik agar tak terlena narasi penguasa

Mahasiswa dari berbagai kampus berpartisipasi dalam aksi Indonesia Gelap di Jakarta untuk memprotes kebijakan pemerintah.@jackjackparrrBermula dari media sosial, tagar #IndonesiaGelap menjadi bentuk a...

Ketika pemberitaan penuh tekanan, bagaimana cara tetap ‘update’ tanpa ‘doomscrolling’?

Mart Production/PexelsAwalnya sesederhana kita mengintip media sosial favorit di tengah malam sebelum tidur. Lalu muncullah judul-judul berita yang menarik perhatian dengan keterangan “breaking ...